HOME

ABOUT US

Actinogen Medical is an Australian clinical stage biotechnology company. The company is focused on the treatment of Alzheimer’s Disease and Mild Cognitive Impairment, a transitional stage of cognitive impairment between normal ageing and the more serious conditions of Alzheimer’s and Dementia. It is developing a novel drug to treat the condition and other age-related neurodegenerative diseases. The lead candidate drug Xanamem™, blocks the development of cortisol which appears to contribute to age related cognitive decline.

PRODUCT DEVELOPMENT

SHARE PRICE INFORMATION

Code: ...

Share Price: ...

Last Updated: ... ...

ASX ANNOUNCEMENTS

SUBSCRIBE TO OUR NEWSLETTER

You can subscribe to receive all company announcements through our Email Alerts service. Please provide your details below to subscribe to our distribution list.
Name
Email *